SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-018824
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:49
Documents
51
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acxp-20230930x10q.htm   iXBRL 10-Q 1244863
2 EX-31.1 acxp-20230930xex31d1.htm EX-31.1 12642
3 EX-31.2 acxp-20230930xex31d2.htm EX-31.2 12647
4 EX-32.1 acxp-20230930xex32d1.htm EX-32.1 5519
5 EX-32.2 acxp-20230930xex32d2.htm EX-32.2 5557
  Complete submission text file 0001558370-23-018824.txt   3982032

Data Files

Seq Description Document Type Size
6 EX-101.SCH acxp-20230930.xsd EX-101.SCH 29697
7 EX-101.CAL acxp-20230930_cal.xml EX-101.CAL 16586
8 EX-101.DEF acxp-20230930_def.xml EX-101.DEF 109894
9 EX-101.LAB acxp-20230930_lab.xml EX-101.LAB 268649
10 EX-101.PRE acxp-20230930_pre.xml EX-101.PRE 205702
45 EXTRACTED XBRL INSTANCE DOCUMENT acxp-20230930x10q_htm.xml XML 421345
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40536 | Film No.: 231398605
SIC: 2834 Pharmaceutical Preparations